首页> 外文期刊>Biomaterials >Use of boron cluster-containing redox nanoparticles with ROS scavenging ability in boron neutron capture therapy to achieve high therapeutic efficiency and low adverse effects
【24h】

Use of boron cluster-containing redox nanoparticles with ROS scavenging ability in boron neutron capture therapy to achieve high therapeutic efficiency and low adverse effects

机译:具有清除ROS能力的含硼团簇的氧化还原纳米粒子在硼中子俘获治疗中的应用达到较高的治疗效率和较低的不良反应

获取原文
获取原文并翻译 | 示例
           

摘要

A boron delivery system with high therapeutic efficiency and low adverse effects is crucial for a successful boron neutron capture therapy (BNCT). In this study, we developed boron cluster-containing redox nanoparticles (BNPs) via polyion complex (PIC) formation, using a newly synthesized poly(-ethylene glycol)-polyanion (PEG-polyanion, possessing a B-10-enriched boron cluster as a side chain of one of its segments) and PEG-polycation (possessing a reactive oxygen species (ROS) scavenger as a side chain of one of its segments). The BNPs exhibited high colloidal stability, selective uptake in tumor cells, specific accumulation, and long retention in tumor tissue and ROS scavenging ability. After thermal neutron irradiation, significant suppression of tumor growth was observed in the BNP-treated group, with only 5-ppm B-10 in tumor tissues, whereas at least 20-ppm B-10 is generally required for low molecular weight (LMW) B-10 agents. In addition, increased leukocyte levels were observed in the LMW B-10 agent-treated group after thermal neutron irradiation, and not in BNP-treated group, which might be attributed to its ROS scavenging ability. No visual metastasis of tumor cells to other organs was observed 1 month after irradiation in the BNP-treated group. These results suggest that BNPs are promising for enhancing the BNCT performance. (C) 2016 Elsevier Ltd. All rights reserved.
机译:具有高治疗效率和低副作用的硼输送系统对于成功的硼中子俘获治疗(BNCT)至关重要。在这项研究中,我们使用新合成的聚(-乙二醇)-聚阴离子(PEG-聚阴离子,具有富含B-10-的硼簇)作为聚合物,通过聚离子络合物(PIC)的形成开发了含硼簇的氧化还原纳米颗粒(BNP)。链段之一的侧链)和PEG-聚阳离子(具有活性氧(ROS)清除剂作为链段之一的侧链)。 BNPs显示出高的胶体稳定性,在肿瘤细胞中的选择性摄取,特异性积累以及在肿瘤组织中的长期保留和ROS清除能力。在热中子辐照后,在BNP治疗组中观察到了显着的肿瘤生长抑制作用,在肿瘤组织中只有5 ppm B-10,而低分子量(LMW)通常至少需要20 ppm B-10。 B-10代理商。此外,在热中子辐照后,在LMW B-10药剂治疗组中观察到白细胞水平升高,而在BNP治疗组中未观察到白细胞水平升高,这可能归因于其清除ROS的能力。 BNP治疗组在照射后1个月未观察到肿瘤细胞向其他器官的视觉转移。这些结果表明,BNP有希望增强BNCT性能。 (C)2016 Elsevier Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号